Apotheek Somers SRL
Apotheek Somers reported total assets of 369,753 € at the end of the 2025 financial year (annual accounts filed with the NBB on 05 Aug 2026).
The score of Apotheek Somers shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +10 % Total assets +1 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Somers's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 61,360 € | ||||
| Equity | 67,449 € | ||||
| Cash | 163,728 € | ||||
| EBITDA | 86,048 € | ||||
| Total assets | 369,753 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 05 Aug 2026
- Year ended 31 Dec 2024filed on 04 Sep 2025
- Year ended 31 Dec 2023filed on 22 Aug 2024
- Year ended 31 Dec 2022filed on 22 Jul 2023
- Year ended 31 Dec 2021filed on 12 Aug 2022
Apotheek Somers's financial analysis
- Solvency18.2%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Somers
Apotheek Somers's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0508.693.932
- VAT number
- BE0508693932
- Peppol
- Registered · 0208:0508693932 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Dec 2012
- Registered office
- 1090 Jette
- Latest accounts
- 2025 · filed on 05 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Somers (SRL) has been based in Jette since 2012, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 61,360 € and equity of 67,449 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apotheek Somers
Companies in the same business, of comparable size and area, outside its group.
- Pharbiomed Retail sale of pharmaceutical products Brussels · balance sheet 369,863 €
- Pharmacie Besonrieux Centre Retail sale of pharmaceutical products La Louvière · balance sheet 377,209 €
- Jumatex Retail sale of pharmaceutical products Saint-Josse-ten-Noode · balance sheet 369,879 €
- La Roue Pharma Retail sale of pharmaceutical products Anderlecht · balance sheet 369,361 €
- Omniphar Retail sale of pharmaceutical products Ronse · balance sheet 369,071 €
- Bogest Retail sale of pharmaceutical products Liège · balance sheet 367,587 €
- Family Pharma Retail sale of pharmaceutical products Brussels · balance sheet 372,644 €
- Acura Pharma Retail sale of pharmaceutical products Brussels · balance sheet 366,408 €
Frequently asked questions about Apotheek Somers
What is the revenue of Apotheek Somers?
Apotheek Somers files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Somers?
In Belgium, the VAT number is the company number prefixed with BE: BE0508693932 for Apotheek Somers, if the company is VAT-registered. Its company number (CBE) is 0508.693.932.
Where is the registered office of Apotheek Somers?
According to the CBE register, the registered office of Apotheek Somers is in 1090 Jette.
What is the equity of Apotheek Somers?
At the close of the 2025 financial year, the equity of Apotheek Somers amounts to 67,449 €, a solvency of 18.2% of total assets.
Who manages Apotheek Somers?
The register lists 2 active mandates at Apotheek Somers. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Somers
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →